FDA Changes Vaping Policy Without Internal Input, Causes Confusion

Senior officials at the FDA’s tobacco center were surprised by a decision that may allow more unauthorized e-cigarettes and nicotine pouches into the U.S. market. These guidelines, published days before the resignation of former FDA Commissioner Marty Makary, enable companies to introduce some nicotine-based products before thorough regulatory evaluation.

FDA staff, responsible for enforcing vaping regulations, were not involved in the decision and only learned of it just before the document’s release. This unexpected development led to internal discussions about the policy’s origins and authorization.

Recent changes have broken from longstanding FDA policy, which needed scientific evidence of health benefits for smokers before introducing new products. Some staff noted that the new guidelines are unusual, as they were drafted without input from those overseeing them.

The true subject matter experts may have opposed this policy and were ordered to do it anyway, said Mitch Zeller, former FDA tobacco director. This affects public trust in institutions like FDA.

The new vaping guidelines bypassed a federally required public comment period. Instead, they were published as a finalized policy soon after media reports indicated that President Donald Trump had approved a plan to remove Makary from his position. He resigned following industry complaints connected to the White House.

Consequences of FDA Policy Changes

A Health and Human Services spokesperson stated that the new approach aims to protect against youth nicotine addiction while supporting adult smokers seeking alternatives to traditional tobacco products.

While health researchers generally acknowledge that e-cigarettes are less harmful than traditional cigarettes, the FDA has long struggled to regulate the market. The agency has approved products from only five companies, rejecting millions of others primarily because of concerns about flavors appealing to children. Unauthorized vapes are still widely available in the U.S.

Shift in Vaping Market

Underage vaping has decreased significantly in the U.S., influenced by the pandemic and new restrictions. Trump’s administration vowed to support the vaping industry, with major tobacco companies like Reynolds American and Altria investing heavily in e-cigarettes and nicotine products.

Despite this, issues with vaping regulation were not prioritized during Makary’s tenure. His interventions sometimes blocked FDA decisions aimed at authorizing certain flavored vapes.

FDA’s new guidelines allow unauthorized nicotine products and require a list of non-authorized e-cigarettes and pouches. These may be sold under enforcement discretion, enabling previously blocked flavors to enter the market.

Bigger Impact on Smaller Firms

The FDA’s approach now targets vapes with youth-appealing features while focusing less on flavors. Based on past practices, the agency intends to act against only certain offenders.

The new policy’s impact on the vaping industry is still undetermined. Larger companies with abundant resources may benefit from the ability to undergo the application review process more easily. Meanwhile, smaller firms fear losing market presence due to these changes.

According to Tony Abboud from the Vapor Technology Association, the new approach may create disparities, giving larger companies an advantage. The FDA’s focus on scientific review may limit market entry for smaller firms.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP remains solely responsible for its content.